Genes involved in predisposition to myelodysplastic syndrome
| Cellular function, syndrome, gene . | Inheritance . | Hematologic malignancy . | Other malignancy . | Variable associated phenotypes . |
|---|---|---|---|---|
| DNA repair | ||||
| Fanconi anemia | ||||
| FANCA | AR | MDS, AML | Squamous cell carcinoma: oral, gastrointestinal, genitourinary; FANCD1/BRCA2 subtype also presents with other solid tumors and ALL. | Bone marrow failure, short stature, hyper/hypopigmentation, facial dysmorphologies, skeletal, digits, hypogonadism, cardiopulmonary, gastrointestinal, endocrinopathies, CNS |
| FANCB | XLR | |||
| FANCC | AR | |||
| FANCD1/BRCA2 | AR | |||
| FANCD2 | AR | |||
| FANCE | AR | |||
| FANCF | AR | |||
| FANCG | AR | |||
| FANCI | AR | |||
| FANCJ/BRIP1/BACH1 | AR | |||
| FANCL | AR | |||
| FANCM | AR | |||
| FANCN/PALB2 | AR | |||
| FANCO/RAD51C | AR | |||
| FANCP/SLX4 | AR | |||
| FANCQ/ERCC4 | AR | |||
| FANCR/RAD51 | AD | |||
| FANCS/BRCA1 | AR | |||
| FANCT/UBE2T | AR | |||
| FANCU/XRCC2 | AR | |||
| FANCV/REV7 | AR | |||
| FANCW/RFWD3 | AR | |||
| Transcription factor | ||||
| Familial platelet disorder with propensity to myeloid malignancy | ||||
| RUNX1 | AD | MDS, AML, T-ALL, hairy cell leukemia | Thrombocytopenia, platelet dysfunction | |
| GATA2-spectrum disorders | ||||
| GATA2 | AD | MDS, AML, CMML, JMML | Emberger syndrome, MonoMac syndrome, immunodeficiencies/immune dysregulation (monocytopenia, B-cell deficiencies, NK cell deficiencies), hearing loss, warts, atypical mycobacterial infections, lymphedema, monocytopenia, marrow failure | |
| Thrombocytopenia 5 | ||||
| ETV6 | AD | ALL, MDS, AML, CMML, MM | Thrombocytopenia, platelet dysfunction | |
| Ribosomal abnormalities | ||||
| Diamond Blackfan anemia | ||||
| GATA1 | AD | MDS, AML | Osteosarcoma, soft tissue sarcomas | Bone marrow failure, short stature, radial ray abnormalities, cardiac, renal anomalies, facial dysmorphisms |
| RPL5 | AD | |||
| RPL11 | AD | |||
| RPL15 | AD | |||
| RPL23 | AD | |||
| RPL26 | AD | |||
| RPL27 | AD | |||
| RPL31 | AD | |||
| RPL35a | AD | |||
| RPL36 | AD | |||
| RPS7 | AD | |||
| RPS10 | AD | |||
| RPS15 | AD | |||
| RPS17 | AD | |||
| RPS19 | AD | |||
| RPS24 | AD | |||
| RPS26 | AD | |||
| RPS27 | AD | |||
| RPS27A | AD | |||
| RPS28 | AD | |||
| RPS29 | AD | |||
| TSR2 | X-linked | |||
| Shwachman Diamond syndrome | ||||
| SBDS | AR | MDS, AML | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies, neurocognitive, other congenital anomalies | |
| DNAJC21 | AR | AML | ||
| EFL1 | AR | ? | ||
| Telomere maintenance | ||||
| DC/TBD | ||||
| DKC1 | XLR | MDS, AML | Oral and gastrointestinal squamous cell carcinoma | Bone marrow failure, nail dystrophy, skin pigmentation abnormalities, oral leukoplakia, idiopathic pulmonary fibrosis, liver disease, short telomeres, immunodeficiencies, vascular anomalies, other congenital anomalies |
| TERC | AD | |||
| TERT | AD, AR | |||
| NOLA3/NOP10 | AR | |||
| NOLA2/NHP2 | AR | |||
| TINF2 | AD | |||
| WRAP53/TCAB1 | AR | |||
| CTC1 | AR | |||
| RTEL1 | AD, AR | |||
| ACD/ TPP1 | AD, AR | |||
| PARN | AD, AR | |||
| NAF1 | AD | |||
| STN1 | AD | |||
| RAS pathway | ||||
| Noonan syndrome | ||||
| PTPN11, SOS1, RAF1, KRAS, NRAS, BRAF, MAP2K1 | AD | JMML, MDS, AML, MPN | Solid tumors | Facial dysmorphism, short stature, cardiac, broad neck, thoracic, cryptorchidism, coagulopathy (Noonan) |
| Noonan-like | ||||
| CBL | AD | JMML, MDS | ||
| Other | ||||
| Severe congenital neutropenia | ||||
| ELANE | AD | MDS, AML (ALL?) | Osteopenia | |
| HAX1 | AR | MDS, AML (ALL?) | Seizures, neurologic abnormalities | |
| GFI1 | AD | MDS, AML | Lymphopenia | |
| G6PC3 | AR | MDS, AML | Neutropenia, congenital heart malformations, prominent superficial veins, urogenital abnormalities, Dursun syndrome | |
| JAGN1 | AR | AML | Skeletal and dental abnormalities | |
| Thrombocytopenia 2 | ||||
| ANKRD26 | AD | MDS, AML, CLL, CMML | Thrombocytopenia, platelet dysfunction | |
| X-linked neutropenia | ||||
| WAS | X-linked | MDS, AML | Immunologic abnormalities, monocytopenia | |
| MIRAGE syndrome, (myelodysplasia, infection, restriction of growth, adrenal insufficiency, genital phenotypes, and enteropathy) | ||||
| SAMD9 | AD | MDS, AML | Cytopenias, immunologic abnormalities, short stature, adrenal hypoplasia, infections, gastrointestinal, genitourinary skeletal, CNS, monosomy 7 | |
| Ataxia-pancytopenia syndrome | ||||
| SAMD9L | AD | MDS, AML | Bone marrow failure, ataxia, monosomy 7 | |
| Neurofibromatosis 1 | ||||
| NF1 | AD | JMML, MDS | Optic gliomas, CNS tumors, malignant peripheral nerve sheath tumors, other solid tumors | Café au lait spots, axillary freckling, Lisch nodules, neurofibromas |
| Bloom syndrome | ||||
| BLM | AR | Lymphoma, ALL, MDS, AML | Short stature, sun-sensitive rash, pulmonary disease, immunodeficiency | |
| Constitutional mismatch repair deficiency | ||||
| MLH1 | AR | ALL, Lymphoma, MDS, AML | Gastrointestinal (colon), ovarian, uterine, CNS, other | |
| MSH2 | AR | |||
| MSH6 | AR | |||
| EPCAM | AR | |||
| PMS2 | AR | |||
| Li-Fraumeni | ||||
| TP53 | AD | ALL, MDS, AML, lymphoma | Breast, osteosarcoma, soft tissue sarcoma, CNS, adrenocortical carcinoma, other | |
| Susceptibility to acute myeloid leukemia | ||||
| DDX41 | AD | MDS, AML, CML, lymphoma | Malignancies present in older age (>50 y) | |
| Familial myeloproliferative neoplasms | ||||
| JAK2 haplotype 46/1 [GGCC], TERT rs2736100_c | AD | PV, ET, PMF | ||
| ATG2B, GSKIP | AD | PV, ET, PMF, CML, CMML, AML | ||
| RBBP6 | AD | PV, ET, PMF | ||
| Myeloid neoplasms associated with trisomy 8 mosaicism | ||||
| Trisomy 8 | Variable | MDS, AML, CML | ||
| Congenital neutropenia or SDS-Like disorder | ||||
| SRP54 | AR | ? | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies | |
| Bone Marrow Failure Syndrome 1 | ||||
| SRP72 | AD | MDS | Bone marrow failure, sensorineural hearing loss |
| Cellular function, syndrome, gene . | Inheritance . | Hematologic malignancy . | Other malignancy . | Variable associated phenotypes . |
|---|---|---|---|---|
| DNA repair | ||||
| Fanconi anemia | ||||
| FANCA | AR | MDS, AML | Squamous cell carcinoma: oral, gastrointestinal, genitourinary; FANCD1/BRCA2 subtype also presents with other solid tumors and ALL. | Bone marrow failure, short stature, hyper/hypopigmentation, facial dysmorphologies, skeletal, digits, hypogonadism, cardiopulmonary, gastrointestinal, endocrinopathies, CNS |
| FANCB | XLR | |||
| FANCC | AR | |||
| FANCD1/BRCA2 | AR | |||
| FANCD2 | AR | |||
| FANCE | AR | |||
| FANCF | AR | |||
| FANCG | AR | |||
| FANCI | AR | |||
| FANCJ/BRIP1/BACH1 | AR | |||
| FANCL | AR | |||
| FANCM | AR | |||
| FANCN/PALB2 | AR | |||
| FANCO/RAD51C | AR | |||
| FANCP/SLX4 | AR | |||
| FANCQ/ERCC4 | AR | |||
| FANCR/RAD51 | AD | |||
| FANCS/BRCA1 | AR | |||
| FANCT/UBE2T | AR | |||
| FANCU/XRCC2 | AR | |||
| FANCV/REV7 | AR | |||
| FANCW/RFWD3 | AR | |||
| Transcription factor | ||||
| Familial platelet disorder with propensity to myeloid malignancy | ||||
| RUNX1 | AD | MDS, AML, T-ALL, hairy cell leukemia | Thrombocytopenia, platelet dysfunction | |
| GATA2-spectrum disorders | ||||
| GATA2 | AD | MDS, AML, CMML, JMML | Emberger syndrome, MonoMac syndrome, immunodeficiencies/immune dysregulation (monocytopenia, B-cell deficiencies, NK cell deficiencies), hearing loss, warts, atypical mycobacterial infections, lymphedema, monocytopenia, marrow failure | |
| Thrombocytopenia 5 | ||||
| ETV6 | AD | ALL, MDS, AML, CMML, MM | Thrombocytopenia, platelet dysfunction | |
| Ribosomal abnormalities | ||||
| Diamond Blackfan anemia | ||||
| GATA1 | AD | MDS, AML | Osteosarcoma, soft tissue sarcomas | Bone marrow failure, short stature, radial ray abnormalities, cardiac, renal anomalies, facial dysmorphisms |
| RPL5 | AD | |||
| RPL11 | AD | |||
| RPL15 | AD | |||
| RPL23 | AD | |||
| RPL26 | AD | |||
| RPL27 | AD | |||
| RPL31 | AD | |||
| RPL35a | AD | |||
| RPL36 | AD | |||
| RPS7 | AD | |||
| RPS10 | AD | |||
| RPS15 | AD | |||
| RPS17 | AD | |||
| RPS19 | AD | |||
| RPS24 | AD | |||
| RPS26 | AD | |||
| RPS27 | AD | |||
| RPS27A | AD | |||
| RPS28 | AD | |||
| RPS29 | AD | |||
| TSR2 | X-linked | |||
| Shwachman Diamond syndrome | ||||
| SBDS | AR | MDS, AML | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies, neurocognitive, other congenital anomalies | |
| DNAJC21 | AR | AML | ||
| EFL1 | AR | ? | ||
| Telomere maintenance | ||||
| DC/TBD | ||||
| DKC1 | XLR | MDS, AML | Oral and gastrointestinal squamous cell carcinoma | Bone marrow failure, nail dystrophy, skin pigmentation abnormalities, oral leukoplakia, idiopathic pulmonary fibrosis, liver disease, short telomeres, immunodeficiencies, vascular anomalies, other congenital anomalies |
| TERC | AD | |||
| TERT | AD, AR | |||
| NOLA3/NOP10 | AR | |||
| NOLA2/NHP2 | AR | |||
| TINF2 | AD | |||
| WRAP53/TCAB1 | AR | |||
| CTC1 | AR | |||
| RTEL1 | AD, AR | |||
| ACD/ TPP1 | AD, AR | |||
| PARN | AD, AR | |||
| NAF1 | AD | |||
| STN1 | AD | |||
| RAS pathway | ||||
| Noonan syndrome | ||||
| PTPN11, SOS1, RAF1, KRAS, NRAS, BRAF, MAP2K1 | AD | JMML, MDS, AML, MPN | Solid tumors | Facial dysmorphism, short stature, cardiac, broad neck, thoracic, cryptorchidism, coagulopathy (Noonan) |
| Noonan-like | ||||
| CBL | AD | JMML, MDS | ||
| Other | ||||
| Severe congenital neutropenia | ||||
| ELANE | AD | MDS, AML (ALL?) | Osteopenia | |
| HAX1 | AR | MDS, AML (ALL?) | Seizures, neurologic abnormalities | |
| GFI1 | AD | MDS, AML | Lymphopenia | |
| G6PC3 | AR | MDS, AML | Neutropenia, congenital heart malformations, prominent superficial veins, urogenital abnormalities, Dursun syndrome | |
| JAGN1 | AR | AML | Skeletal and dental abnormalities | |
| Thrombocytopenia 2 | ||||
| ANKRD26 | AD | MDS, AML, CLL, CMML | Thrombocytopenia, platelet dysfunction | |
| X-linked neutropenia | ||||
| WAS | X-linked | MDS, AML | Immunologic abnormalities, monocytopenia | |
| MIRAGE syndrome, (myelodysplasia, infection, restriction of growth, adrenal insufficiency, genital phenotypes, and enteropathy) | ||||
| SAMD9 | AD | MDS, AML | Cytopenias, immunologic abnormalities, short stature, adrenal hypoplasia, infections, gastrointestinal, genitourinary skeletal, CNS, monosomy 7 | |
| Ataxia-pancytopenia syndrome | ||||
| SAMD9L | AD | MDS, AML | Bone marrow failure, ataxia, monosomy 7 | |
| Neurofibromatosis 1 | ||||
| NF1 | AD | JMML, MDS | Optic gliomas, CNS tumors, malignant peripheral nerve sheath tumors, other solid tumors | Café au lait spots, axillary freckling, Lisch nodules, neurofibromas |
| Bloom syndrome | ||||
| BLM | AR | Lymphoma, ALL, MDS, AML | Short stature, sun-sensitive rash, pulmonary disease, immunodeficiency | |
| Constitutional mismatch repair deficiency | ||||
| MLH1 | AR | ALL, Lymphoma, MDS, AML | Gastrointestinal (colon), ovarian, uterine, CNS, other | |
| MSH2 | AR | |||
| MSH6 | AR | |||
| EPCAM | AR | |||
| PMS2 | AR | |||
| Li-Fraumeni | ||||
| TP53 | AD | ALL, MDS, AML, lymphoma | Breast, osteosarcoma, soft tissue sarcoma, CNS, adrenocortical carcinoma, other | |
| Susceptibility to acute myeloid leukemia | ||||
| DDX41 | AD | MDS, AML, CML, lymphoma | Malignancies present in older age (>50 y) | |
| Familial myeloproliferative neoplasms | ||||
| JAK2 haplotype 46/1 [GGCC], TERT rs2736100_c | AD | PV, ET, PMF | ||
| ATG2B, GSKIP | AD | PV, ET, PMF, CML, CMML, AML | ||
| RBBP6 | AD | PV, ET, PMF | ||
| Myeloid neoplasms associated with trisomy 8 mosaicism | ||||
| Trisomy 8 | Variable | MDS, AML, CML | ||
| Congenital neutropenia or SDS-Like disorder | ||||
| SRP54 | AR | ? | Bone marrow failure, short stature, exocrine pancreatic dysfunction, skeletal dysplasias, immunodeficiencies | |
| Bone Marrow Failure Syndrome 1 | ||||
| SRP72 | AD | MDS | Bone marrow failure, sensorineural hearing loss |
AD, autosomal dominant; AR, autosomal recessive; CMML, chronic myelomonocytic leukemia; ET, essential thrombocythemia; JMML, juvenile myelomonocytic leukemia; PMF, primary myelofibrosis; PV, polycythemia vera.
Because of space limitations, this table is not exhaustive and readers are referred to additional references cited in the text.